Complete mesocolic resection and extended lymphadenectomy for colon cancer: a systematic review
Corresponding Author
S. Killeen
Department of Colorectal Surgery, St. Vincent's University Hospital, Elm Park, Dublin, Ireland
Correspondence to: S. Killeen, Surgical Professorial Unit, St Vincent's University Hospital, Elm Park, Dublin 4, Ireland.
E-mail: [email protected]
Search for more papers by this authorM. Mannion
Department of Colorectal Surgery, St. Vincent's University Hospital, Elm Park, Dublin, Ireland
Search for more papers by this authorA. Devaney
Department of Colorectal Surgery, St. Vincent's University Hospital, Elm Park, Dublin, Ireland
Search for more papers by this authorD. C. Winter
Department of Colorectal Surgery, St. Vincent's University Hospital, Elm Park, Dublin, Ireland
Search for more papers by this authorCorresponding Author
S. Killeen
Department of Colorectal Surgery, St. Vincent's University Hospital, Elm Park, Dublin, Ireland
Correspondence to: S. Killeen, Surgical Professorial Unit, St Vincent's University Hospital, Elm Park, Dublin 4, Ireland.
E-mail: [email protected]
Search for more papers by this authorM. Mannion
Department of Colorectal Surgery, St. Vincent's University Hospital, Elm Park, Dublin, Ireland
Search for more papers by this authorA. Devaney
Department of Colorectal Surgery, St. Vincent's University Hospital, Elm Park, Dublin, Ireland
Search for more papers by this authorD. C. Winter
Department of Colorectal Surgery, St. Vincent's University Hospital, Elm Park, Dublin, Ireland
Search for more papers by this authorAbstract
Aim
Complete mesocolic excision (CME) and extended lympha-denectomy (EL) have been proposed as safe procedures for improving colon cancer survival outcomes. The aim of this study was to evaluate the evidence regarding oncological outcomes, morbidity and mortality after such techniques for colon cancer.
Method
A systematic review of the literature was conducted to evaluate evidence regarding oncological outcomes, morbidity and mortality after CME or EL. Three major databases (PubMed, MEDLINE and the Cochrane Library) were searched. The review included original articles reporting outcomes after CME or EL from January 1950 to July 2012.
Results
Twenty-one, predominately retrospective, studies involving 5246 patients (mean age 68.2 years, 56.5% men) were included. Reporting of outcomes was inconsistent. Median follow up was 60 months. The operative mortality rate was 3.2% and the cumulative morbidity rate was 21.5%. The weighted mean local recurrence rate and the 5-year overall and disease-free survival rates were 4.5%, 58.1% and 77.4%, respectively.
Conclusion
The available data for CME and EL have numerous fundamental limitations that prohibit adoption. Contemporary controlled studies are required before universal recommendation.
References
- 1Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation–technical notes and outcome. Colorectal Dis 2009; 11: 354–64.
- 2Weber K, Merkel S, Perrakis A, Hohenberger W. Is there a disadvantage to radical lymph node dissection in colon cancer? Int J Colorectal Dis 2013; 28: 217–26.
- 3Mukai M, Ito I, Mukoyama S et al. Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes’ B and C colorectal cancer: a 17-year retrospective study. Oncol Rep 2003; 10: 927–34.
- 4Hida J, Okuno K, Yasutomi M et al. Optimal ligation level of the primary feeding artery and bowel resection margin in colon cancer surgery: the influence of the site of the primary feeding artery. Dis Colon Rectum 2005; 48: 2232–7.
- 5Tagliacozzo S, Tocchi A. Extended mesenteric excision in right hemicolectomy for carcinoma of the colon. Int J Colorectal Dis 1997; 12: 272–5.
- 6Bokey EL, Chapuis PH, Dent OF, Mander BJ, Bissett IP, Newland RC. Surgical technique and survival in patients having a curative resection for colon cancer. Dis Colon Rectum 2003; 46: 860–6.
- 7Rosenberg J, Fischer A, Haglind E. Current controversies in colorectal surgery: the way to resolve uncertainty and move forward. Colorectal Dis 2011; 14: 266–9.
- 8Hogan AM, Winter DC. Mesocolic plane surgery: just plain surgery? Colorectal Dis 2009; 11: 430–1.
- 9Hogan AM, Winter DC. Complete mesocolic excision (CME): a “novel” concept? J Surg Oncol 2009; 100: 182–3.
- 10Feng B, Sun J, Ling TL et al. Laparoscopic complete mesocolic excision (CME) with medial access for right-hemi colon cancer: feasibility and technical strategies. Surg Endosc 2012; 26: 3669–75.
- 11Adamina M, Manwaring ML, Park KJ, Delaney CP. Laparoscopic complete mesocolic excision for right colon cancer. Surg Endosc 2012; 26: 2976–80.
- 12Kobayashi M, Okamoto K, Namikawa T, Okabayashi T, Araki K. Laparoscopic lymph node dissection around the inferior mesenteric artery for cancer in the lower sigmoid colon and rectum: is D3 lymph node dissection with preservation of the left colic artery feasible? Surg Endosc 2006; 20: 563–9.
- 13Sun YW, Chi P, Lin HM, Lu XR, Huang Y, Xu ZB, Huang SH. [Comparison of efficacy between laparoscopic versus open complete mesocolic excision for colon cancer]. Zhonghua Wei Chang Wai Ke Za Zhi 2012; 15: 24–7.
- 14McDonald JR, Renehan AG, O'Dwyer ST, Haboubi NY. Lymph node harvest in colon and rectal cancer: current considerations. World J Gastrointest Surg 2012; 4: 9–19.
- 15Baxter NN, Ricciardi R, Simunovic M, Urbach DR, Virnig BA. An evaluation of the relationship between lymph node number and staging in pT3 colon cancer using population-based data. Dis Colon Rectum 2010; 53: 65–70.
- 16Bui L, Rempel E, Reeson D, Simunovic M. Lymph node counts, rates of positive lymph nodes, and patient survival for colon cancer surgery in Ontario, Canada: a population-based study. J Surg Oncol 2006; 93: 439–45.
- 17Wong SL, Ji H, Hollenbeck BK, Morris AM, Baser O, Birkmeyer JD. Hospital lymph node examination rates and survival after resection for colon cancer. JAMA 2007; 298: 2149–54.
- 18Mathis KL, Green EM, Sargent DJ, Delaney C, Simmang CL, Nelson H. Surgical quality surrogates do not predict colon cancer survival in the setting of technical credentialing: a report from the prospective COST trial. Ann Surg 2013: 257: 102–7.
- 19Hogan AM, Winter DC. Complete mesocolic excision—A marker of surgical quality? J Gastrointest Surg 2009; 13: 1889–91.
- 20Hjorth M, Holmberg E, Rödjer S, Westin J. Impact of active and passive exclusions on the results of a clinical trial in multiple myeloma. The Myeloma Group of Western Sweden. Br J Haematol 1992; 80: 55–61.
- 21Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009; 151: 264–9.
- 22Stang A. Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25: 603–5.
- 23Kanemitsu Y, Hirai T, Komori K, Kato T. Survival benefit of high ligation of the inferior mesenteric artery in sigmoid colon or rectal cancer surgery. Br J Surg 2006; 93: 609–15.
- 24Hasegawa S, Kawamura J, Nagayama S, Nomura A, Kondo K, Sakai Y. Medially approached radical lymph node dissection along the surgical trunk for advanced right-sided colon cancers. Surg Endosc 2007; 21: 1657.
- 25Tentes AA, Mirelis C, Karanikiotis C, Korakianitis O. Radical lymph node resection of the retroperitoneal area for left-sided colon cancer. Langenbecks Arch Surg 2007; 392: 155–60.
- 26Liang JT, Huang KC, Lai HS, Lee PH, Sun CT. Oncologic results of laparoscopic D3 lymphadenectomy for male sigmoid and upper rectal cancer with clinically positive lymph nodes. Ann Surg Oncol 2007; 14: 1980–90.
- 27Lee SD, Lim SB. D3 lymphadenectomy using a medial to lateral approach for curable right-sided colon cancer. Int J Colorectal Dis 2009; 24: 295–300.
- 28Ovrebo K, Rokke O. Extended lymph node dissection in colorectal cancer surgery. Reliability and reproducibility in assessments of operative reports. Int J Colorectal Dis 2010; 25: 213–22.
- 29Bertelsen A, Bols B, Ingeholm P, Jansen JE, Neuenschwander AU, Vilandt J. Can the quality of colonic surgery be improved by standardization of surgical technique with complete mesocolic excision? Colorectal Dis 2011; 13: 1123–9.
- 30Pramateftakis MG. Optimizing colonic cancer surgery: high ligation and complete mesocolic excision during right hemicolectomy. Tech Coloproctol 2010; 14(Suppl 1): S49–51.
- 31Eiholm S, Ovesen H. Total mesocolic excision versus traditional resection in right-sided colon cancer - method and increased lymph node harvest. Dan Med Bull 2010; 57: A4224.
- 32Lan YT, Lin JK, Jiang JK, Chang SC, Liang WY, Yang SH. Significance of lymph node retrieval from the terminal ileum for patients with cecal and ascending colonic cancers. Ann Surg Oncol 2011; 18: 146–52.
- 33Hashiguchi Y, Hase K, Ueno H, Mochizuki H, Shinto E, Yamamoto J. Optimal margins and lymphadenectomy in colonic cancer surgery. Br J Surg 2011; 98: 1171–8.
- 34West NP, Kobayashi H, Takahashi K et al. Understanding optimal colonic cancer surgery: comparison of Japanese D3 resection and European complete mesocolic excision with central vascular ligation. J Clin Oncol 2012; 30: 1763–9.
- 35Han DP, Lu AG, Feng H et al. Long-term results of laparoscopy-assisted radical right hemicolectomy with D3 lymphadenectomy: clinical analysis with 177 cases. Int J Colorectal Dis 2012; 26: 3669–7.
- 36West NP, Morris EJ, Rotimi O et al. Pathology grading of colon cancer surgical resection and its association with survival: a retrospective observational study. Lancet Oncol 2008; 9: 857–65.
- 37West NP, Hohenberger W, Weber K, Perrakis A, Finan PJ, Quirke P. Complete mesocolic excision with central vascular ligation produces an oncologically superior specimen compared with standard surgery for carcinoma of the colon. J Clin Oncol 2010; 28: 272–8.
- 38Rothwell PM. External validity of randomised controlled trials: “to whom do the results of this trial apply?”. Lancet 2005; 365: 82–93.
- 39Yu XQ, Baade PD, O'Connell DL. Conditional survival of cancer patients: an Australian perspective. BMC Cancer 2012; 12: 460.
- 40Graham JS, Cassidy J. Adjuvant therapy in colon cancer. Expert Rev Anticancer Ther 2012; 12: 99–109.
- 41Ma Y, Yang Z, Qin H, Wang Y. A meta-analysis of laparoscopy compared with open colorectal resection for colorectal cancer. Med Oncol 2011; 28: 925–33.
- 42Braga M, Frasson M, Zuliani W, Vignali A, Pecorelli N, Di Carlo V. Randomized clinical trial of laparoscopic versus open left colonic resection. Br J Surg 2010; 97: 1180–6.
- 43You YN, Chua HK, Nelson H, Hassan I, Barnes SA, Harrington J. Segmental vs. extended colectomy: measurable differences in morbidity, function, and quality of life. Dis Colon Rectum 2008; 51: 1036–43.
- 44Yun HR, Lee LJ, Park JH et al. Local recurrence after curative resection in patients with colon and rectal cancers. Int J Colorectal Dis 2008; 23: 1081–7.
- 45 Foxtrot Collaborative Group. Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial. Lancet Oncol 2012; 13: 1152–60.
Citing Literature
